World Equity Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,398
Closed -$202K 338
2022
Q1
$202K Buy
+4,398
New +$210K 0.04% 343

Other funds holding ARKG

World Equity Group's ARKG Position: Q2 2022 in Review

World Equity Group sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 4,398 shares — an estimated $202K sold.

World Equity Group first reported a position in ARKG in Q1 2022 and held it in 1 quarter. The position peaked at $202K in Q1 2022. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

  • World Equity Group reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
  • World Equity Group sold 4,398 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $202K.
  • World Equity Group first reported a position in ARK Genomic Revolution ETF in Q1 2022 and held it in 1 quarter.
  • World Equity Group's ARK Genomic Revolution ETF position peaked at $202K in Q1 2022.
  • 333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on World Equity Group's 13F filing for Q2 2022, filed 6 Sep 2024.